Effectiveness of Baricitinib for Nasal, Genital, and Beard Hair Regrowth in Patients with Severe Alopecia Areata: 12-Month Outcomes from a Prospective Observational Study

Main Article Content

Justin Ko
Stanford University School of Medicine, Palo Alto, USA

Karan Lal
Affiliated Dermatology, Scottsdale, USA, Northwell Health. Glen Cove, USA

Michelle Tarbox
Texas Tech University Health Sciences Center, Lubbock, USA

Susan Ball
Eli Lilly and Company, Indianapolis, USA

Angelina Sontag
Eli Lilly and Company, Indianapolis, USA

Firas Dabbous
Thermo Fisher Scientific, Waltham, USA

Mary Kate Ladd
Thermo Fisher Scientific, Waltham, USA

Klaudia Kornalska
Thermo Fisher Scientific, Waltham, USA

Najwa Somani
Eli Lilly and Company, Indianapolis, USA

Jerry Shapiro
New York University Grossman School of Medicine, New York, USA

Keywords

Alopecia Areata

References

N/A

Article Sidebar

PDF
Published
2025-11-10
DOI: https://doi.org/10.25251/698xev04

Article Details

How to Cite
1.
Effectiveness of Baricitinib for Nasal, Genital, and Beard Hair Regrowth in Patients with Severe Alopecia Areata: 12-Month Outcomes from a Prospective Observational Study. J of Skin. 2025;9(6):s670. doi:10.25251/698xev04
Issue
Vol. 9 No. 6 (2025): November 2025 Issue
Section
Alopecia
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.

Most read articles by the same author(s)

1 2 3 > >>